Coya Therapeutics, Inc. Earnings Per Share (Basic)
Coya Therapeutics, Inc. (COYA) reported Earnings Per Share (Basic) of -$0.28 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Coya Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.28.
- Coya Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.32.
- Coya Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.34.
- Coya Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.13.
- Coya Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$1.27.
- Coya Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$0.98.
- Coya Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$0.79.
- Coya Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$4.73.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.28 10-Q · filed 2026-08-11 | -$0.60 10-Q · filed 2026-08-11 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2026-03-31 | -$0.32 10-Q · filed 2026-05-12 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.27 10-K · filed 2026-03-16 |
| 2025-09-30 | -$0.13 10-Q · filed 2025-11-12 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.93 10-Q · filed 2025-11-12 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.36 10-Q · filed 2026-08-11 | -$0.80 10-Q · filed 2026-08-11 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.25 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.44 10-Q · filed 2026-05-12 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2024-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.98 10-K · filed 2026-03-16 |
| 2024-09-30 | -$0.26 10-Q · filed 2025-11-12 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.80 10-Q · filed 2025-11-12 | -$0.77 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.19 10-Q · filed 2025-08-12 | -$0.54 10-Q · filed 2025-08-12 | -$0.50 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-03-31 | -$0.35 10-Q · filed 2025-05-13 | -$0.30 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.61 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.91 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2023-12-31 | $0.11 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.21 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.51 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.79 10-K · filed 2025-03-18 |
| 2023-09-30 | -$0.34 10-Q · filed 2024-11-06 | -$0.66 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$0.94 10-Q · filed 2024-11-06 | -$1.54 derived: net income ÷ weighted average shares · filed 2024-11-06 |
| 2023-06-30 | -$0.31 10-Q · filed 2024-08-12 | -$0.59 10-Q · filed 2024-08-12 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$2.09 derived: net income ÷ weighted average shares · filed 2024-11-06 |
| 2023-03-31 | -$0.28 10-Q · filed 2024-05-09 | -$0.95 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$1.99 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$3.04 derived: net income ÷ weighted average shares · filed 2024-11-06 |
| 2022-12-31 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$2.75 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$4.07 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$4.73 10-K · filed 2024-03-19 |
| 2022-09-30 | -$1.55 10-Q · filed 2023-11-08 | -$2.87 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$3.53 10-Q · filed 2023-11-08 | |
| 2022-06-30 | -$1.32 10-Q · filed 2023-08-08 | -$1.98 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.66 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$1.89 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |